Compare AQST & AEXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AQST | AEXA |
|---|---|---|
| Founded | 2004 | 2025 |
| Country | United States | United States |
| Employees | 142 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.0M | 554.5M |
| IPO Year | 2007 | N/A |
| Metric | AQST | AEXA |
|---|---|---|
| Price | $4.07 | $11.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 116.7K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,430,000.00 | N/A |
| Revenue This Year | $14.23 | N/A |
| Revenue Next Year | $58.36 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.20 | $10.49 |
| 52 Week High | $7.55 | $11.91 |
| Indicator | AQST | AEXA |
|---|---|---|
| Relative Strength Index (RSI) | 47.73 | 44.99 |
| Support Level | $3.69 | $10.98 |
| Resistance Level | $4.46 | $11.25 |
| Average True Range (ATR) | 0.21 | 0.26 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 30.09 | 48.00 |
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
American Exceptionalism Acquisition Corp A is a blank check company.